Correlation Between Anebulo Pharmaceuticals and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Entrada Therapeutics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Entrada Therapeutics.
Diversification Opportunities for Anebulo Pharmaceuticals and Entrada Therapeutics
-0.63 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Anebulo and Entrada is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Entrada Therapeutics
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Entrada Therapeutics. In addition to that, Anebulo Pharmaceuticals is 2.27 times more volatile than Entrada Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.19 per unit of volatility. If you would invest 1,699 in Entrada Therapeutics on August 26, 2024 and sell it today you would earn a total of 181.00 from holding Entrada Therapeutics or generate 10.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Entrada Therapeutics
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Entrada Therapeutics |
Anebulo Pharmaceuticals and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Entrada Therapeutics
The main advantage of trading using opposite Anebulo Pharmaceuticals and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
| Entrada Therapeutics vs. Eliem Therapeutics | Entrada Therapeutics vs. HCW Biologics | Entrada Therapeutics vs. Scpharmaceuticals | Entrada Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |